Related Experiment Video
Updated: Dec 27, 2025

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Formulating a Stable Mannitol Infusion while Maintaining Hyperosmolarity
Oisín Kavanagh1, Fiona Hogan1, Caoimhe Murphy1
1Solid State Pharmaceutical Centre (SSPC), The Science Foundation Ireland Research Centre for Pharmaceuticals, Department of Chemical Sciences, Bernal Institute, University of Limerick, V94 T9PX Limerick, Ireland.
Abstract:
Mannitol infusion is commonly used in the treatment of intracranial hypertension following traumatic brain injury. It has long been known to have stability issues, specifically, mannitol recrystallises from solutions greater than 10% w/v in ambient conditions. This can happen at any time, whether on the pharmacy shelf or during a medical procedure. This study describes the stability limits of 20% w/v mannitol infusion (the most common strength used clinically) and proposes a number of safer, stable and tuneable hyperosmotic formulations of mannitol in combination with clinically acceptable osmotic agents (NaCl, sorbitol and glycerol).
Related Concept Videos
Osmosis and Osmotic Pressure of Solutions
Formation of Concentrated Urine
Formation of Dilute Urine
Filtrate Osmolarity in the PCT
Initially, as the filtrate passes through the proximal convoluted tubule (PCT), its...
Tonicity in Animals
Tonicity in Animals
Factors Influencing Microbial Growth: Osmolarity

